Cargando…
Causes, comorbidities and current status of chronic kidney disease: A community perspective from North Kerala
CONTEXT: Chronic kidney disease is an upcoming public health problem characterized by premature mortality and expensive treatment in low resource settings where diabetes is highly prevalent. AIM: To find out the causes and comorbidities and to explore the community support systems for treatments ava...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820375/ https://www.ncbi.nlm.nih.gov/pubmed/31681656 http://dx.doi.org/10.4103/jfmpc.jfmpc_478_19 |
Sumario: | CONTEXT: Chronic kidney disease is an upcoming public health problem characterized by premature mortality and expensive treatment in low resource settings where diabetes is highly prevalent. AIM: To find out the causes and comorbidities and to explore the community support systems for treatments availed. SETTINGS AND DESIGN: Community based cross sectional design. MATERIALS AND METHODS: Interview of known chronic kidney disease patients above 18 years registered under palliative clinics. STATISTICAL ANALYSIS USED: Mean, SD, proportions, and 95% Confidence interval, chi square test at significance level P = 0.05. RESULTS: Majority of patients were males, below 60 years. Mean duration was 5.26 years and mean age at onset was 48.6 years and 62% were in advanced stages of disease. The commonest cause was diabetic nephropathy (44.6%) followed by hypertensive nephropathy (33.3%). The comorbidities included hypertension (61.4%), diabetes (47.3%), cardiovascular disease (30.6%), Chronic obstructive pulmonary disease (10%) malignancies (2.6%), and retinopathy (28%). Considering treatment status 60.6% were on dialysis 13.3% had undergone transplantation, mostly from private institutions with help of public donations and both at significant underutilization by women. Though 44.6% were protected by social security schemes, the median monthly cost of disease management amounted to Rs. 10,500 which was unaffordable for the majority who were below the poverty line. CONCLUSIONS: There is an impending need for strengthening management, high-risk screening among diabetic and hypertensive patients and provision for specialist care to delay the onset of end-stage renal disease. The social security support system should be improvised for our setting to facilitate dialysis and transplantation to minimize out of the pocket expenditure. |
---|